Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Socié, Gérard  [Clear All Filters]
2014
van Laar, J.M., Farge, D., Sont, J.K., Naraghi, K., Marjanovic, Z., Larghero, J., Schuerwegh, A.J., Marijt, E.W.A., Vonk, M.C., Schattenberg, A.V., et al. (2014). Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis: A Randomized Clinical Trial.Jama311, 2490-2498.
Itzykson, R., Robin, M., Moins-Teisserenc, H., Delord, M., Busson, M., Xhaard, A., de Fontbrune, F.Sicre, de Latour, R.Peffault, Toubert, A., and Socié, G. (2014). Cytomegalovirus shapes long-term immune reconstitution after allogeneic stem cell transplantation.Haematologica.
Brüggen, M.-C., Petzelbauer, P., Greinix, H., Contassot, E., Jankovic, D., French, L., Socié, G., Rabitsch, W., Kuzmina, Z., Kalhs, P., et al. (2014). Epidermal Elafin Expression is an Indicator of Poor Prognosis in Cutaneous Graft-versus-Host Disease.J Invest Dermatol.
Loschi, M., Porcher, R., de Latour, R.Peffault, Vanneaux, V., Robin, M., Xhaard, A., de Fontebrune, F.Sicre, Larghero, J., and Socié, G. (2014). High Number of memory T cells is associated with higher risk Of acute GVHD after allogeneic stem cell transplantation.Biol Blood Marrow Transplant.
Glauzy, S., Soret, J., Fournier, I., Douay, C., Moins-Teisserenc, H., de Latour, R.Peffault, Maki, G., Robin, M., Socié, G., Toubert, A., et al. (2014). Impact of acute and chronic Graft-vs-Host Disease on human B-cell generation and replication.Blood.
Meunier, M., Manez, A.-C., Xhaard, A., de Latour, R.Peffault, de Fontbrune, F.Sicre, Dhedin, N., Socié, G., and Robin, M. (2014). Late Donor Bone Marrow Failure After Allogeneic Hematopoietic Stem Cell Transplantation.Transplantation97, e75-e77.
Schlemmer, F., Chevret, S., Lorillon, G., De Bazelaire, C., de Latour, R.Peffault, Meignin, V., Michallet, M., Hermet, E., Wyplosz, B., Houdouin, V., et al. (2014). Late-onset noninfectious interstitial lung disease after allogeneic hematopoietic stem cell transplantation.Respir Med.
Chevallier, P., Labopin, M., Socié, G., Tabrizi, R., Furst, S., Lioure, B., Guillaume, T., Delaunay, J., de la Tour, R.Peffault, Vigouroux, S., et al. (2014). Results from a clofarabine-busulfan containing reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase II prospective CLORIC trial.Haematologica.
Brissot, E., Labopin, M., Beckers, M.M., Socié, G., Rambaldi, A., Volin, L., Finke, J., Lenhoff, S., Kröger, N., Ossenkoppele, G.J., et al. (2014). Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.Haematologica.

Pages